Evidence map›Paper›PMID 39394558›Full record

ArticleJournal of translational medicine2024

Immunometabolic changes and potential biomarkers in CFS peripheral immune cells revealed by single-cell RNA sequencing.

Yujing Sun, Zhenhua Zhang, Qincheng Qiao, Ying Zou, Lina Wang, Tixiao Wang, Bo Lou, Guosheng Li, Miao Xu, Yanxiang Wang and 4 more

Abstract read
In one paragraph

Article in Journal of translational medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Yujing SunDepartment of Endocrinology and Metabolism, Cheeloo College of Medicine, Qilu Hospital, Shandong University, Jinan, 250012, China.
Zhenhua ZhangSchool of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, Guangdong, China.
Qincheng QiaoDepartment of Endocrinology and Metabolism, Cheeloo College of Medicine, Qilu Hospital, Shandong University, Jinan, 250012, China.
Ying ZouDepartment of Endocrinology and Metabolism, Cheeloo College of Medicine, Qilu Hospital, Shandong University, Jinan, 250012, China.
Lina WangDepartment of Endocrinology and Metabolism, Cheeloo College of Medicine, Qilu Hospital, Shandong University, Jinan, 250012, China.
Tixiao WangDepartment of Endocrinology and Metabolism, Cheeloo College of Medicine, Qilu Hospital, Shandong University, Jinan, 250012, China.
Bo LouDepartment of Neurology, the Third People's Hospital of Liaocheng, Liaocheng, 252000, Shandong Province, China.
Guosheng LiDepartment of Hematology, Qilu Hospital of Shandong University, Jinan, 250012, Shandong Province, China.
Miao XuDepartment of Hematology, Qilu Hospital of Shandong University, Jinan, 250012, Shandong Province, China.
Yanxiang WangJinan AXZE Medical Test Laboratory, Jinan, 250012, Shandong Province, China.
Zhenhong ZhangJinan AXZE Medical Test Laboratory, Jinan, 250012, Shandong Province, China.
Xinguo HouDepartment of Endocrinology and Metabolism, Cheeloo College of Medicine, Qilu Hospital, Shandong University, Jinan, 250012, China.
Li ChenDepartment of Endocrinology and Metabolism, Cheeloo College of Medicine, Qilu Hospital, Shandong University, Jinan, 250012, China.
Ruxing ZhaoDepartment of Endocrinology and Metabolism, Cheeloo College of Medicine, Qilu Hospital, Shandong University, Jinan, 250012, China. Zhaoruxing@qiluhospital.com.ORCID 0000-0002-8893-1007

Funding

National Natural Science Foundation of China 81500631National Natural Science Foundation of China 82070868National Natural Science Foundation of China 82200918National Natural Science Foundation of China 82370853Natural Science Foundation of Shandong Province ZR2021QC111
6 · The paper itself

Abstract

The pathogenesis of Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) remains unclear, though increasing evidence suggests inflammatory processes play key roles. In this study, single-cell RNA sequencing (scRNA-seq) of peripheral blood mononuclear cells (PBMCs) was used to decipher the immunometabolic profile in 4 ME/CFS patients and 4 heathy controls. We analyzed changes in the composition of major PBMC subpopulations and observed an increased frequency of total T cells and a significant reduction in NKs, monocytes, cDCs and pDCs. Further investigation revealed even more complex changes in the proportions of cell subpopulations within each subpopulation. Gene expression patterns revealed upregulated transcription factors related to immune regulation, as well as genes associated with viral infections and neurodegenerative diseases.CD4

Indexed as

BiomarkersFatigue Syndrome, ChronicLeukocytes, MononuclearSequence Analysis, RNASingle-Cell AnalysisAdultFemaleGene Expression RegulationHumansKiller Cells, NaturalMaleMiddle AgedBiomarkersBiomarkersImmune dysregulationImmunometabolismMyalgic encephalomyelitis/Chronic fatigue syndrome (ME/CFS)Peripheral blood mononuclear cells (PBMCs)Single-cell RNA sequencing (scRNA-seq)

Identifiers

PMID39394558
PMCPMC11468054

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.